These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37026883)

  • 1. Drugs in Development for Chronic Spontaneous Urticaria.
    Nguyen W; Liu W; Yamauchi P
    J Drugs Dermatol; 2023 Apr; 22(4):393-397. PubMed ID: 37026883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune chronic spontaneous urticaria.
    Kolkhir P; Muñoz M; Asero R; Ferrer M; Kocatürk E; Metz M; Xiang YK; Maurer M
    J Allergy Clin Immunol; 2022 Jun; 149(6):1819-1831. PubMed ID: 35667749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of clinical factors as possible predictors of response to omalizumab and relapse after treatment discontinuation in chronic spontaneous urticaria.
    Foti C; Romita P; Ambrogio F; Fanelli M; Panebianco R; Vena GA; Cassano N; Ragusa M; Giuffrida R; Papaianni V; Borgia F; Cannavò SP; Guarneri F
    Dermatol Ther; 2022 Feb; 35(2):e15248. PubMed ID: 34877757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies.
    Orzan OA; Popa LG; Mihai MM; Cojocaru A; Giurcăneanu C; Dorobanțu AM
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances.
    Kaplan A; Lebwohl M; Giménez-Arnau AM; Hide M; Armstrong AW; Maurer M
    Allergy; 2023 Feb; 78(2):389-401. PubMed ID: 36448493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease.
    Martina E; Diotallevi F; Bianchelli T; Paolinelli M; Offidani A
    Curr Pharm Biotechnol; 2021; 22(1):32-45. PubMed ID: 32603278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and treatment response of chronic spontaneous urticaria according to age: A single-center Korean study.
    Jo YH; Yoo HW; Kim SH; Kim YM; Kim HY
    Asian Pac J Allergy Immunol; 2022 Dec; 40(4):374-378. PubMed ID: 31837210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between adult and pediatric chronic spontaneous urticaria from a cohort of 751 patients: Clinical features, associated conditions and indicators of treatment response.
    Özçeker D; Can PK; Terzi Ö; Ornek SA; Değirmentepe EN; Kızıltac K; Sarac E; Kocatürk E
    Pediatr Allergy Immunol; 2023 Feb; 34(2):e13925. PubMed ID: 36825740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology, Diagnosis, and Management of Chronic Spontaneous Urticaria: A Literature Review.
    Greiner B; Nicks S; Adame M; McCracken J
    Clin Rev Allergy Immunol; 2022 Dec; 63(3):381-389. PubMed ID: 36048326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab on Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Real-World Study of Efficacy and Predictors of Treatment Outcome.
    Jeong SH; Lim DJ; Chang SE; Kim KH; Kim KJ; Park EJ
    J Korean Med Sci; 2022 Jul; 37(27):e211. PubMed ID: 35818702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric chronic spontaneous urticaria: a brief clinician's guide.
    Votto M; Achilli G; De Filippo M; Licari A; Marseglia A; Moiraghi A; Di Sabatino A; Marseglia GL
    Expert Rev Clin Immunol; 2022 Sep; 18(9):889-899. PubMed ID: 35833360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Existing and Investigational Medications for Refractory Chronic Spontaneous Urticaria: Safety, Adverse Effects, and Monitoring.
    Kocaturk E; Saini SS; Rubeiz CJ; Bernstein JA
    J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3099-3116. PubMed ID: 36241154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn's Disease.
    Barni S; Giovannini M; Liccioli G; Sarti L; Gissi A; Lionetti P; Mori F
    Front Immunol; 2021; 12():635069. PubMed ID: 33737936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of omalizumab in Chinese patients with anti-histamine refractory chronic spontaneous urticaria.
    Yuan W; Hu S; Li M; Yang L; Liu L; Zheng M; Guo Z; Song Z; Zhang C; Diao Q; Xu J; Richard A; Patwardhan M; Lyu T; Uddin A; Fogel R; Ligueros-Saylan M; Zheng J
    Dermatol Ther; 2022 Apr; 35(4):e15303. PubMed ID: 34984792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic spontaneous urticaria in the United States: patient characteristics and treatment patterns.
    Pourali SP; Gutierrez Y; Kucharik AH; Rajkumar JR; Jones ME; Armstrong AW
    Int J Dermatol; 2022 Aug; 61(8):e308-e309. PubMed ID: 34370872
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.
    Maurer M; Costa C; Gimenez Arnau A; Guillet G; Labrador-Horrillo M; Lapeere H; Meshkova R; Savic S; Chapman-Rothe N
    Clin Exp Allergy; 2020 Oct; 50(10):1166-1175. PubMed ID: 32735720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging treatments for chronic spontaneous urticaria.
    Johal KJ; Saini SS
    Ann Allergy Asthma Immunol; 2020 Oct; 125(4):380-387. PubMed ID: 31494233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy.
    Liao SL; Yu M; Zhao ZT; Maurer M
    Front Immunol; 2021; 12():652973. PubMed ID: 33796115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Urticaria in Children: an Update on Diagnosis and Treatment.
    Wang EA; Chan SK
    Curr Allergy Asthma Rep; 2020 Jun; 20(8):31. PubMed ID: 32506151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria-CURE Results.
    Kolkhir P; Laires PA; Salameh P; Asero R; Bizjak M; Košnik M; Dissemond J; van Doorn M; Hawro T; Kasperska-Zajac A; Zajac M; Kocatürk E; Peter J; Parisi CAS; Ritchie CA; Kulthanan K; Tuchinda P; Fomina D; Kovalkova E; Khoshkhui M; Kouzegaran S; Papapostolou N; Du-Thanh A; Kamegashira A; Meshkova R; Vitchuk A; Bauer A; Grattan C; Staubach P; Bouillet L; Giménez-Arnau AM; Maurer M; Weller K
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):610-620.e5. PubMed ID: 36481420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.